|
NUDT19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.575890E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.840100E-04 |
| Normal-vs-Stage2 |
4.404900E-04 |
| Normal-vs-Stage3 |
1.300670E-03 |
| Normal-vs-Stage4 |
2.615900E-02 |
| Stage1-vs-Stage2 |
2.272000E-01 |
| Stage1-vs-Stage3 |
7.783000E-01 |
| Stage1-vs-Stage4 |
3.891800E-01 |
| Stage2-vs-Stage3 |
3.323000E-01 |
| Stage2-vs-Stage4 |
8.415600E-02 |
| Stage3-vs-Stage4 |
3.223600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.790600E-04 |
| Normal-vs-AfricanAmerican |
6.802200E-02 |
| Normal-vs-Asian |
2.161800E-02 |
| Caucasian-vs-AfricanAmerican |
7.363200E-01 |
| Caucasian-vs-Asian |
3.486000E-01 |
| AfricanAmerican-vs-Asian |
8.716000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58919999999618E-05 |
| Normal-vs-Female |
1.715760E-03 |
| Male-vs-Female |
1.194490E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.898000E-03 |
| Normal-vs-Age(41-60Yrs) |
5.775900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.10849999999763E-05 |
| Normal-vs-Age(81-100Yrs) |
1.088360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.404800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.035630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.041800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.573800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.176600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.507000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.691400E-01 |
| Classical-VS-Follicular |
8.699000E-01 |
| Classical-VS-Other |
9.376000E-01 |
| Classical-VS-Normal |
1.047390E-04 |
| Tall-VS-Follicular |
9.506000E-01 |
| Tall-VS-Other |
9.561000E-01 |
| Tall-VS-Normal |
1.314360E-02 |
| Follicular-VS-Other |
9.805400E-01 |
| Follicular-VS-Normal |
1.939340E-03 |
| Other-VS-Normal |
1.391180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.642800E-04 |
| Normal-vs-N1 |
1.330370E-01 |
| N0-vs-N1 |
4.936400E-02 |
|
|
